First, separate a real MDT from a series of separate appointments
The phrase multidisciplinary team is used loosely. In some hospitals it means cardiology, electrophysiology, cardiac surgery and anaesthesia sit together, review the same file and produce one documented recommendation. In others it means you see several specialists on different days and each writes their own note. Both can be useful, but they answer different questions and they cost you different amounts of time.
For atrial fibrillation specifically, the distinction matters because the decisions overlap. Whether to pursue rhythm control, whether catheter ablation is reasonable, whether a surgical or hybrid approach is worth discussing, and how anticoagulation is managed are not independent choices. If the electrophysiologist and the surgeon never speak, you may receive two plans that cannot both be followed.
So the first question is administrative, not clinical: what form will the discussion take? Ask whether there is a scheduled joint meeting, who attends, whether a written summary is produced, and whether you receive that summary in English. Ask whether the discussion happens before you travel or only after admission. Ask who is responsible for telling you the outcome.
You should also ask what happens if the specialties disagree. A genuine MDT should be able to state the points of disagreement rather than smoothing them into a single sentence. If the answer is that disagreement is unlikely, that is itself information about how the process works.
What your rhythm-monitoring results actually show
An MDT cannot give a useful opinion without knowing what rhythm you have and how often you have it. Paroxysmal, persistent and long-standing persistent atrial fibrillation behave differently, and the same procedure is not equally reasonable across those patterns. The discussion needs your actual monitoring data, not a summary that says atrial fibrillation.
Bring the original recordings where possible: Holter or event-monitor reports, ECG strips, smartwatch or consumer-device recordings if they were used, and any loop recorder data. Include the dates, the total monitoring duration and how much of that time was in atrial fibrillation or another atrial arrhythmia. A single ECG from an emergency visit tells the team very little about your burden over a month.
The MDT should answer: what is the documented rhythm, how much is it affecting you, and has anything changed since the last assessment. If your monitoring is old or incomplete, the discussion may conclude that more rhythm documentation is needed before a procedure is recommended. That is a legitimate outcome, not a rejection.
Ask specifically whether the team considers your pattern suitable for the approach being discussed. Catheter ablation treats selected abnormal heart rhythms by targeting the tissue responsible, and the approach depends on the rhythm problem. That is a general principle, not a prediction about your case. The treating clinicians must confirm individual suitability.
Previous ablation, previous medicines and what was already tried
A first ablation and a second ablation are different decisions. The MDT needs to know whether you have had a previous ablation, when, at which hospital, what technique was used, and what the outcome was. If a prior procedure was partially successful, the team needs the original procedure report, not just your recollection.
The same applies to medicines. Bring a dated list of every rhythm-control and rate-control medicine you have taken, the dose, how long you took it, and why it was stopped or changed. Include anticoagulants separately, with the current agent, dose and who prescribed it. Do not stop or change any of these medicines on your own before the discussion.
The MDT should answer: what has already been tried, what failed or was not tolerated, and whether anything remains untried that would change the recommendation. If the answer is that a medicine was never given a proper trial, that may alter the plan. If the answer is that you have already failed several options, the discussion shifts toward procedure-based rhythm control.
Ask whether the team needs records from the hospital that performed your earlier procedure. Original electrophysiology study reports, ablation lesion sets and fluoroscopy or mapping data can matter. If those records are unavailable, say so early so the team can decide how much weight to place on the remaining information.
The rhythm-control goal, stated in measurable terms
A vague goal such as get your rhythm under control is not something you can evaluate afterward. The MDT should state what it is trying to achieve and how that will be judged. Is the goal freedom from atrial fibrillation, a reduction in burden, better rate control, fewer symptoms, or something else? These are not the same target.
Ask how success will be assessed and over what period. Ask what monitoring will be used after any change in treatment. Ask what would count as a partial result and what would count as failure. Ask what the next step would be in each case. You are not asking for a guarantee; you are asking for a plan you can understand.
The MDT should also address what happens if the chosen approach does not work. For atrial fibrillation, a second procedure, a change in medicine, or a decision to accept rate control may all be reasonable depending on your situation. The discussion should say which of these the team would consider and why.
If the team cannot describe the goal in specific terms, that is a signal to ask more questions before committing to travel or to a procedure. A clear goal also helps your local clinician understand what was proposed and why.
Anticoagulation, stroke risk and who manages it
Anticoagulation is often the part of atrial fibrillation care that patients most want clarified, and it is the part an MDT should address explicitly. The discussion should answer who is responsible for your anticoagulation before, during and after any procedure, and what the plan is if a procedure is not performed.
Ask what your current stroke-risk assessment is, what agent and dose are recommended, and whether that recommendation differs from what you take now. Ask what happens if a procedure is planned: whether the anticoagulant is continued, interrupted or bridged, and who makes that decision. Do not change anything yourself based on a general article.
The MDT should also state what monitoring is needed while you take an anticoagulant and who will review it. If you are travelling to China for assessment, ask how anticoagulation will be managed during the trip and who you contact if there is a problem. Bleeding or clotting symptoms need urgent local assessment, not an email.
If the team recommends a change to anticoagulation, ask for the reason in writing and share it with the clinician who normally manages your care. A records-based opinion does not replace your local prescriber's judgement.
What to confirm in writing, and the limits of any MDT opinion
Before you commit to travel or to a procedure, ask for the MDT outcome in writing. The document should state who took part, what records were reviewed, what was recommended, what alternatives were considered, and what remains uncertain. If the discussion was based on incomplete records, that limitation should be stated.
Ask what the recommendation does and does not establish. An MDT opinion is not hospital acceptance, not a confirmed procedure date, and not a guarantee of a particular outcome. Suitability is decided by the treating hospital after it reviews your case. If a trial, device or therapy is mentioned, ask separately whether it is actually available to you and on what basis.
Ask about the practical sequence: what happens after the MDT, who contacts you, what additional tests or records are needed, and what the next decision point is. Ask whether the plan changes if you decide not to travel. A good MDT answer should still be useful to your local team.
Finally, ask what you should do if your symptoms worsen before any planned care. New or worsening chest pain, severe breathlessness, fainting or signs of stroke require urgent local medical attention. An overseas enquiry should never delay that.
If you want to start this process, you can send a brief summary of your diagnosis, your main question and your available rhythm records through the free initial case review. The team will tell you what is missing and what the relevant next step is. You do not need to buy a proxy consultation to make an initial enquiry, and no hospital is obliged to provide a formal MDT.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.